Practical preparation
Preparing for an Ibogaine Experience: Medical Evaluation Checklist
A structured way to prepare for clinician conversations about cardiac screening, medication history, baseline tests, records, and timing before any ibogaine dose.
Preparation is part of the safety conversation.
For people researching ibogaine, a medical evaluation is not a box to check after a decision has been made. It is the process that helps identify information a clinician needs before considering whether participation is appropriate at all.
This ibogaine medical evaluation checklist is designed to help organize questions and records. It does not replace individualized assessment, urgent care, or advice from a qualified clinician. The broader Ibogaine Treatment resource can help situate these preparation questions alongside evidence, practical concerns, and uncertainty.
Why a standardized medical evaluation matters
Ibogaine has been associated with potentially serious cardiac effects, including changes in cardiac electrical activity. A standardized evaluation gives clinicians a consistent way to look for known risks, clarify uncertain findings, and determine whether more assessment is needed before any dose is discussed.
That structure matters because health histories can be incomplete, medication lists can change, and travel or withdrawal plans can add risk. The U.S. Food and Drug Administration explains that drug development and safety assessment depend on evaluating risks before and during human use; its overview of the drug development process is a useful reminder that safety questions require more than a single data point.
A careful evaluation is compatible with interest in ibogaine’s promise and research. It also recognizes that more research is needed, and that an individual’s medical history may matter as much as the general discussion.
Essential cardiovascular screening (ECG, QTc measurement, electrolytes, and when to repeat)
A cardiovascular review should begin with a complete history: fainting, palpitations, chest symptoms, known arrhythmias, heart disease, family history of sudden death, and prior ECG findings. An electrocardiogram (ECG) is commonly used to record the heart’s electrical activity. The National Heart, Lung, and Blood Institute describes an electrocardiogram test as a way to detect electrical signals and rhythm changes.
Ask how QTc will be measured and interpreted, and whether a finding needs confirmation. The QT interval is the part of an ECG associated with ventricular electrical recovery; long QT syndrome is one established context in which a prolonged QT can be clinically significant. Interpretation belongs with a clinician who can account for the whole record rather than a number viewed in isolation.
- Bring prior ECGs, cardiology reports, and a list of cardiac symptoms or diagnoses.
- Ask whether potassium, magnesium, calcium, and other electrolyte results are current enough for the planned timeline.
- Ask when ECG and electrolyte testing should be repeated if there is illness, dehydration, vomiting, medication change, withdrawal, or a delay before travel.
- Ask what findings would pause the process and what follow-up would be needed.
Normal results from an earlier test do not automatically answer a later question. Timing, current medications, and changes in health can affect what a clinician needs to review.
“The most useful checklist is one that makes important information easier to disclose, verify, and discuss before risk is taken.”
Medication and substance history: what to disclose and common high-risk interactions
Prepare a complete list of prescriptions, over-the-counter products, supplements, recent medications, and substances. Include dose, schedule, last use, prescriber, and the reason each item is used. Do not omit medications because they feel unrelated; a clinician needs the full picture to evaluate possible interactions and safe changes.
Questions about stopping or tapering medication must be handled with the prescriber who knows the medication and the person’s health history. Abrupt discontinuation can itself cause harm. In particular, medication changes involving psychiatric drugs, opioids, stimulants, heart medicines, and other substances should not be self-directed.
Many readers begin with the site’s Safety & Risks discussion, then use the appointment to ask which specific interactions, withdrawal issues, or washout periods may apply. A clinician may also need to consider substances used recently, not only those intended for use on the day of an ibogaine experience.
Baseline labs and other exams (liver, renal, thyroid, pregnancy test)
Baseline laboratory testing can help a clinician identify conditions that may affect medication handling, electrolyte balance, or overall medical stability. The exact panel and timing should be determined by the evaluating clinician, but conversations often include liver and renal function, thyroid testing when clinically appropriate, blood counts, and electrolytes.
For people who could be pregnant, ask whether a pregnancy test is needed and how the result affects next steps. A clinician may also recommend additional exams or specialist review based on symptoms, chronic conditions, or prior results.
Bring the original reports whenever possible rather than relying on a verbal summary. Dates, reference ranges, and notes about whether a result was repeated can all be relevant. If a result is outside the stated range, ask what it means in context and whether it needs confirmation before decisions are made.
Mental-health screening and suicide/self-harm risk protocols
A thorough preparation conversation also includes mental-health history, current symptoms, prior psychiatric care, current supports, and any history of self-harm or suicidal thoughts. This is not a judgment about whether someone is “serious enough” to seek help; it is part of assessing what support and safety planning may be needed.
Be direct about recent changes in mood, sleep, agitation, psychosis, trauma symptoms, and suicidal thinking. The U.S. National Institute of Mental Health provides practical information about suicide prevention, including the importance of immediate support when someone is in danger. If there is an immediate risk of self-harm, seek emergency help in the local area rather than relying on travel or a future treatment plan.
Ask what screening protocol is used, who reviews the information, how an acute concern changes the plan, and what follow-up support is expected afterward. Clear answers are part of responsible preparation.
Logistics for documentation: medical records, test timing, and travel considerations
Make one concise packet: current medication list, allergies, diagnoses, prior ECGs, relevant lab reports, specialist notes, emergency contacts, and a timeline of recent substance use or medication changes. Keep copies for yourself as well as the clinician reviewing your case.
Confirm the age requirements for each test before spending money or arranging travel. Ask which reports must be original, whether results need to be sent in advance, what may require retesting, and how acute illness or a travel delay should be handled. Timing is not administrative detail when a result can change.
Legal context may affect where and how people research ibogaine access. Before making plans, use the Legal & Access Guide to frame questions about location-specific rules and verify current information through appropriate local sources. Do not assume that a plan considered in one jurisdiction carries over to another.
How to use the checklist with clinicians and questions to ask before any dose
Use this checklist to make a conversation more complete, not to decide independently that screening is sufficient. Share the full record, ask for plain-language explanations, and leave room for a clinician to recommend more testing, specialist input, a delay, or a decision not to proceed.
Questions worth taking with you
- Which parts of my health history change the risk assessment?
- Which ECG, QTc, and electrolyte results do you need, and how recent must they be?
- Which medications or substances require review by my existing prescriber before any change?
- What specific findings would require repeat testing, referral, delay, or a decision not to proceed?
- What emergency and follow-up plans are in place for my circumstances?
For an independent overview of organizations and options people may encounter while researching, ibogaine treatment center research can be one starting point, but it should not substitute for individualized medical assessment. Preparation is strongest when it is candid, current, and guided by qualified clinical judgment.